Axsome Therapeutics, Inc. (0HKF.L)

USD 94.11

(0.14%)

Inventory Summary of Axsome Therapeutics, Inc.

  • Axsome Therapeutics, Inc.'s latest annual inventory in 2023 was 15.13 Million USD , up 250.35% from previous year.
  • Axsome Therapeutics, Inc.'s latest quarterly inventory in 2024 Q2 was 15.22 Million USD , down -2.33% from previous quarter.
  • Axsome Therapeutics, Inc. reported annual inventory of 4.31 Million USD in 2022, down 0.0% from previous year.
  • Axsome Therapeutics, Inc. reported annual inventory of - USD in 2021, down 0.0% from previous year.
  • Axsome Therapeutics, Inc. reported quarterly inventory of 15.58 Million USD for 2024 Q1, up 2.96% from previous quarter.
  • Axsome Therapeutics, Inc. reported quarterly inventory of 9.25 Million USD for 2023 Q2, up 16.52% from previous quarter.

Annual Inventory Chart of Axsome Therapeutics, Inc. (2023 - 2013)

Historical Annual Inventory of Axsome Therapeutics, Inc. (2023 - 2013)

Year Inventory Inventory Growth
2023 15.13 Million USD 250.35%
2022 4.31 Million USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%

Peer Inventory Comparison of Axsome Therapeutics, Inc.

Name Inventory Inventory Difference
Editas Medicine, Inc. - USD -Infinity%
Dynavax Technologies Corporation 53.29 Million USD 71.599%
Supernus Pharmaceuticals, Inc. 77.4 Million USD 80.448%
Perrigo Company plc 1.14 Billion USD 98.673%
Illumina, Inc. 587 Million USD 97.422%
Thermo Fisher Scientific Inc. 5.08 Billion USD 99.703%
Iovance Biotherapeutics, Inc. 10.37 Million USD -45.922%
Walgreens Boots Alliance, Inc. 8.32 Billion USD 99.818%
IQVIA Holdings Inc. - USD -Infinity%
Heron Therapeutics, Inc. 42.11 Million USD 64.058%
Regeneron Pharmaceuticals, Inc. 2.58 Billion USD 99.413%
Unity Biotechnology, Inc. - USD -Infinity%
Waters Corporation 516.23 Million USD 97.068%
Biogen Inc. 2.52 Billion USD 99.401%
Sangamo Therapeutics, Inc. - USD -Infinity%
Evolus, Inc. 10.99 Million USD -37.616%
Adicet Bio, Inc. - USD -Infinity%
Cara Therapeutics, Inc. 2.82 Million USD -436.512%
bluebird bio, Inc. 22.91 Million USD 33.963%
Esperion Therapeutics, Inc. 65.62 Million USD 76.936%
FibroGen, Inc. 41.56 Million USD 63.587%
Agilent Technologies, Inc. 1.03 Billion USD 98.532%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Homology Medicines, Inc. - USD -Infinity%
Geron Corporation - USD -Infinity%
Alnylam Pharmaceuticals, Inc. 89.14 Million USD 83.022%
Amicus Therapeutics, Inc. 59.69 Million USD 74.647%
Myriad Genetics, Inc. 20.1 Million USD 24.701%
Viking Therapeutics, Inc. - USD -Infinity%
Intellia Therapeutics, Inc. - USD -Infinity%
Zoetis Inc. 2.56 Billion USD 99.41%
Abeona Therapeutics Inc. -2.44 Million USD 719.272%
Mettler-Toledo International Inc. 385.86 Million USD 96.078%
BioMarin Pharmaceutical Inc. 1.1 Billion USD 98.633%
Vertex Pharmaceuticals Incorporated 738.8 Million USD 97.951%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 28.42 Million USD 46.755%
Atara Biotherapeutics, Inc. 9.7 Million USD -55.934%
Verastem, Inc. - USD -Infinity%
Nektar Therapeutics 16.1 Million USD 6.0%
Aclaris Therapeutics, Inc. - USD -Infinity%
Sarepta Therapeutics, Inc. 322.85 Million USD 95.312%
OPKO Health, Inc. 65.69 Million USD 76.962%
Exelixis, Inc. 17.32 Million USD 12.631%
Neurocrine Biosciences, Inc. 38.3 Million USD 60.483%
Corcept Therapeutics Incorporated 7.73 Million USD -95.796%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 12.02 Million USD -25.873%
Imunon, Inc. - USD -Infinity%
Blueprint Medicines Corporation 21.22 Million USD 28.686%
Insmed Incorporated 83.24 Million USD 81.819%
Halozyme Therapeutics, Inc. 127.6 Million USD 88.139%
Agios Pharmaceuticals, Inc. 19.07 Million USD 20.659%
TG Therapeutics, Inc. 39.82 Million USD 61.994%
Incyte Corporation 62.97 Million USD 75.966%
Emergent BioSolutions Inc. 328.9 Million USD 95.398%